![Charlie Latham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charlie Latham
Corporate Officer/Principal bei
Australian Institute of Co. Directors
Profil
Charlie J.
Latham is currently a Member at the Australian Institute of Co. Directors and a Secretary at Carina Biotech Pty Ltd. He previously worked as the Chief Financial Officer & Secretary at Austofix Group Ltd. from 2008 to 2011.
Aktive Positionen von Charlie Latham
| Unternehmen | Position | Beginn |
|---|---|---|
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | 23.06.2011 |
Carina Biotech Pty Ltd.
 Carina Biotech Pty Ltd. BiotechnologyHealth Technology Develops chimeric antigen receptor T-cell therapies to treat cancers | Unternehmenssekretär | 05.06.2023 |
Ehemalige bekannte Positionen von Charlie Latham
| Unternehmen | Position | Ende |
|---|---|---|
Austofix Group Ltd.
 Austofix Group Ltd. Medical SpecialtiesHealth Technology Designs and manufactures surgical appliances | Finanzdirektor/CFO | 16.03.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
100
+
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Austofix Group Ltd.
Austofix Group Ltd. Medical SpecialtiesHealth Technology Designs and manufactures surgical appliances | Health Technology |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Develops chimeric antigen receptor T-cell therapies to treat cancers | Health Technology |
